Integration of GWAS data in COVID-19 identified SNPs associated with natural variation in the expression of specific genes, including the viral M protein-proximal TRIM4 activator of type I interferon, that may contribute to disease susceptibility differences in the human population. This evidence concerns the gene TRIM4 and COVID-19.